CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 63 filers reported holding CUE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 890,000 | $7,503,000 | 0.50% |
| Nantahala Capital Management | 1,378,198 | $11,618,000 | 0.43% |
| 683 Capital Management, LLC | 300,000 | $2,529,000 | 0.28% |
| Rock Creek Group, LP | 42,505 | $358,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $422,000 | 0.06% |
| Parian Global Management LP | 11,000 | $93,000 | 0.04% |
| Sigma Planning Corp | 60,210 | $508,000 | 0.02% |
| D'Orazio & Associates, Inc. | 2,000 | $17,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 26,602 | $224,000 | 0.01% |
| STIFEL FINANCIAL CORP | 55,855 | $471,000 | 0.00% |